Verelan PM

This page contains recent news articles, when available, and an overview of Verelan PM but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

First-Time Generic Approvals: Verelan PM, Cefotan, Nasarel  -  Aug 17, 2007
August 17, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for verapamil hydrochloride 100-, 200-, ... Medscape

Hispanic Community Needs Increased Awareness of Hypertension …  -  Feb 14, 2005
Verelan PM, a chronotherapeutic dosage form of the calcium channel blocker verapamil, ... Verelan PM is dosed once daily at bedtime and is available in ... Free with registration - PR Newswire - AccessMyLibrary.com

Calcium Channel Blocking Agents (Systemic).  -  Aug 1, 2006
Adults and teenagers For (Verelan): 240 to 480 mg once a day For (Verelan PM): 200 mg once a day at bedtime . Children -- Dose must be determined by your ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Calcium Channel Blocking Agents (Systemic).(Drug overview)  -  May 1, 2006
Adults and teenagers For (Verelan): 240 to 480 mg once a day For (Verelan PM): 200 mg once a day at bedtime . Children -- Dose must be determined by your ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Korean War vet receives Medal of Honor 55 years after his heroics  -  Oct 24, 2005
Also included were the calcium channel blockers Verelan, Verelan PM, Covera HS, Cardizem LA, Norvasc, DynaCirc, DynaCirc CR, Cardene and Cardene SR. ... Providence Journal

Mylan unit gets regulatory OK for generic Verelan capsules  -  Aug 10, 2007
N said its unit has received final approval from the US Food and Drug Administration for a generic version of Elan Drug Delivery Inc.'s Verelan PM ER ... Reuters

Mylan Announces Final FDA Approval For Verapamil Hydrochloride …  -  Aug 14, 2007
Mylan Laboratories Inc. (NYSE: MYL) announced that Mylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration for its ... Medical News Today - Medical News Today (press release)

Zestoretic Oral : User Ratings covering uses, effectiveness, interacti...  -  May 23, 2008
I currently take Zestoretic in combination with Verelan PM for high blood pressure. This has been an effective combination of medications for my hpertension ... WebMD

Event Brief of Q2 2007 Mylan Laboratories Earnings Conference Call - ...  -  Nov 1, 2006
Verapamil hydrochloride, generic Verelan PM. 3. Desloratadine, generic of Clarinex. 6. Outlook: 1. Excited about completing the closing of Matrix ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Caldwell: An update on Veterans' benefits  -  Dec 7, 2005
The calcium channel blockers Covera HS, Cardizem LA, Novasc, DynaCir CR, Cardene and Cardene SR, Norvasc, Verelan and Verelan PM. ... wickedlocal.com

Company Profile Report  -  Mar 29, 2008
Verelan/Verelan PM (Verapamil Hydrochloride). Dermatology. Lesion/Scaling Disorders. Dermatoses. Steroidal Anti-Inflammatory Drugs (SAID)/Sodium Channel ... $50.00 - Revere Reports - Revere

Schwarz's 1st-qtr sales up 4% to 274M euros.(launch of Neupro)( …  -  May 8, 2006
After adjusting for the generic business, the group's US revenues rose 4.7% to 44.2 million, primarily attributable to the cardiovascular drugs Verelan PM ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Competitors by Product Report  -  Mar 29, 2008
Products:. Verelan/Verelan PM (Verapamil Hydrochloride). Abbott Laboratories (ABT) Products:. Isoptin SR (Verapamil Hydrochloride); KOS Pharmaceuticals ... $75.00 - Revere Reports - Revere

Q1 2006 Schwarz Pharma AG Earnings Conference Call - Part 1.  -  Apr 25, 2006
Here especially Verelan PM had a nice sales rebound. The generics were down 1.7% due to the competitive environment. However, as I have said before, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Schwartz Pharma boosted by US sales.(sales and earnings)(Brief...  -  May 2, 2005
It also noted that, while Verelan PM (verapamil) benefited in the prior year from the timing of customer orders, it did not repeat the previous performance, ... $4.95 - Pharma Marketletter - ECNext

Verapamil HCl extended-release capsules.  -  Sep 3, 2007
Mylan Pharmaceuticals, Pittsburgh, (724) 514-1800, has been granted final approval for generic Verelan PM, a product of Elan Pharma. ... $9.94 - Drug Topics - Alacra Store

Toviaz therapy.(RXs)(Schwarz Pharma get apporval )(Brief article) | …  -  Nov 24, 2008
Schwarz Pharma has launched Verelan PM for the management of essential hypertension. The product, being copromoted with Elan Corp., is now available in an ... Pay-Per-View - Chain Drug Review - HighBeam Research

Kansas Regulations - 129-5-1. Prior authorization.  -  Nov 3, 2005
...with the following brand names: (i) Covera HS® and (ii) Verelan PM® (C) nifedipine sustained release, with the following brand names: (i) Nifedical XL® ... Pay-Per-View - Kansas Regulations - Loislaw

Verapamil HCl extended-release capsules.(NEW GENERICS)(Elan …  -  Sep 3, 2007
Mylan Pharmaceuticals, Pittsburgh, (724) 514-1800, has been granted final approval for generic Verelan PM, a product of Elan Pharma. $4.95 - Drug Topics - ECNext

Article: HU star researchers take Kaye Prizes for innovation. Hashish...  -  Jun 13, 2006
Article: Study Confirms Bedtime Dosing With Chronotherapeutic Verelan PM ... Business Wire; September 3, 2002 ; 700+ words ... ... control of morning blood ... Pay-Per-View - Jerusalem Post - HighBeam Research

Aportan 25 mdp en medicamentos a la Secretaría de Salud  -  Jan 22, 2008
...entre los que se encuentran Verelan PM de 200 miligramos cuya fórmula es Verapamil por un total de 180 cajas y cada caja trae 16 recipientes. ... oem.com.mx





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy